Cannabis Policy
Experts Claim Proposed Californian Cannabis Regulations Could Put Medical Cannabis Users at Risk of Infection
Californian cannabis users could be put at serious risk from fungal and bacterial contaminants as new regulations lack effective safety screenings, despite the state’s Quality Control Committee specifically advocating for such tests.
American Osteopathic Association Declares Support for Review of Medical Cannabis
The American Osteopathic Association supports the reclassification of cannabis as a Schedule II Drug to facilitate advancement in clinical, public health, patient safety and health policy research, according to a resolution approved by the AOA House of Delegates.
British Government Set to Loosen Rules on Medicinal Cannabis
The changes concern the reclassification of cannabis to make it a schedule 2 drug, allowing it to be prescribed by medical professionals and possessed lawfully by anybody with a valid medical prescription.
Medical Cannabis Users Could Still be Criminalised in UK Despite Government Accepting its Benefits
Under current recommendations, people who use cannabis for conditions including chronic pain, arthritis, the side effects of chemotherapy and even the self-medication of brain and other tumours, will continue to be criminalised.
Torts and Courts: How the Cannabis Industry Can Protect Itself from Legal Action
The cannabis industry has largely escaped negligence cases to date, mainly due to legal uncertainties - experts claim this ‘tort cease-fire’ is coming to an end.
Crime Clearance Rates Positively Impacted by Cannabis Legalization
In Colorado and Washington arrest rates for cannabis has fallen and crime clearance rates for violent crime, burglary, motor vehicle theft and property crime have shifted upward.
Multiple Case Studies Show Potential Danger of Cannabis Contaminants
Preventive steps and remediative action are required to reduce the prevalence of contamination from microbes, heavy metals and, pesticides.
CBD Market Set to Grow as Regulatory Change Looms in U.S.
The market for cannabis and hemp products has seen a low-key but potentially huge step forward in recent weeks.
A Big Step Forward for Medical Marijuana
Medical marijuana has picked up considerable momentum after a U.S. FDA advisory panel unanimously recommended approval of GW Pharmaceuticals' epilepsy medication, Epidolex.
